The Lung Cancer Therapeutics Market size was valued at US$ 31.19 Billion in 2025 and is projected to reach US$ 79.06 Billion by 2033, growing at a CAGR of 12.3% during 2026–2033. Market growth is best understood as the interaction between customer demand, operating economics, and supplier execution. The opportunity expands when buyers see measurable value, but commercialization still...